PAA 2.27% 22.5¢ pharmaust limited

Ann: Appendix 4C & Company Update - Sep 2018, page-27

  1. 148 Posts.
    lightbulb Created with Sketch. 39
    Talk about misleading, don't know which slide to go for... try the last:

    1. 'Approval in Canines for larger trials' - what approval? Has NOT been approved in Canines
    2. 'The Pivotal Trial for moving forward: Cancer Control' Pivotal - says who? It's controlling Cancer now!?
    3. Second Half of 2019 - chronologically must come AFTER mid 2019 - how is said event possible before!?
    4. Assuming somehow it is before (as it reads) 'Canine Cancer - Disease Free Interval and Long Term Survival'... Since when has that ever actually happened? how could they claim that!?
    5. Potential date for exercise option - what option? Ashton's share options?
    6. RETURN TO HUMAN TRIALS FOLLOWING DATA FROM CANINES AND EXPLORE FAST TRACK REGISTRATION!!! Don't need to submission and approval to start a human trial first? Don't need multiple animal species and a full pharm-tox package not just dog? Don't need Fast Track Designation BEFORE even consideration of a Fast Track Registration!!?

    Most importantly, these are just start dates of made up events - how long until any results let alone a return?
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $100.1M
Open High Low Value Volume
22.0¢ 22.5¢ 21.5¢ $194.1K 889.8K

Buyers (Bids)

No. Vol. Price($)
2 4996 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 114999 4
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.